Citation Impact

Citing Papers

Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction
1999 Standout
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: A dilemma and a challenge
1981
Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol
1990
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial Infarction
1988
Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials
2014
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Cardiovascular drug class specificity: β-blockers
2004
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Pharmacotherapy for critical limb ischaemia
2000
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
The Future of Memory: Remembering, Imagining, and the Brain
2012 StandoutNobel
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease
1992 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Long-term Results of Aortoiliac Reconstruction
1990
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas
2010
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Practical methods for incorporating summary time-to-event data into meta-analysis
2007 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Effect of timolol on mortality and reinfarction after acute myocardial infarction: Prognostic importance of heart rate at rest
1986
Noninvasive physiologic tests in the diagnosis and characterization of peripheral arterial occlusive disease
1973
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Arterial hemodynamics in human hypertension.
1986
A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.
2009
Evaluating the federal role in financing health-related research
1996 StandoutNobel
Cardiovascular neural regulation explored in the frequency domain.
1991 Standout
A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease
1986
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials
1986
Hemodynamic Predictors of Myocardial Oxygen Consumption During Static and Dynamic Exercise
1974
Quantitative Synthesis in Systematic Reviews
1997 Standout
Elevation of Ambulatory Systolic Blood Pressure in Hypertensive Smokers
1991
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Effect of very early intervention with metoprolol on myocardial infarct size.
1983
Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease
1984
Propranolol in the Treatment of Acute Myocardial Infarction
1974
Effects of timolol and propranolol on inducible sustained ventricular tachyarrhythmias in dogs with subacute myocardial infarction
1984
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Improvement of Walking Distance in Patients with Intermittent Claudication by Chronic Local Therapy with Isosorbide Dinitrate Ointment
1988
Blood pressure, stroke, and coronary heart disease
1990 Standout
Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients
1982
Effect of parasympathetic impairment on the haemodynamic response to handgrip in Chagas's heart disease.
1986
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
Mechanisms of Diabetic Complications
2013 Standout
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
1983
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION
1982
Relationship between Doppler pulsatility index and direct femoral pressure measurements in the diagnosis of aortoiliac occlusive disease
1983
Exercise and Hypertension
2004 Standout
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
Prognostic Factors in Acute Pulmonary Edema
1986
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
1986
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
1987 Standout
Effect of propranolol in postinfarction patients with mechanical or electrical complications.
1984
A Long-Term Prevention Study with Oxprenolol in Coronary Heart Disease
1982
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Large-Scale Characterization and Analysis of the Murine Cardiac Proteome
2009
EFFECTIVENESS OF LOW-DOSE HEPARIN IN PREVENTION OF MYOCARDIAL REINFARCTION
1987
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Prostaglandin E1 in severe lower limb ischaemia: A double-blind controlled trial
1984
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination.
1991
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout

Works of E Lorentsen being referenced

The Influence of Venous Collecting Pressure On Measurements of Calf Blood Flow By Venous Occlusion Plethysmography
1970
The Acute Effects of Nifedipine on Calf and Forefoot Blood Flow in Patients with Peripheral Arterial Insufficiency
1983
EVALUATION OF THE FUNCTIONAL IMPORTANCE OF ATHEROSCLEROTIC OBLITERATIONS IN THE AORTO‐ILIAC ARTERY BY PRESSURE/FLOW MEASUREMENTS
1972
Vasodilator drugs in the treatment of peripheral arterial insufficiency.
1974
Haemodynamic effects of propranolol (Inderal) in acute myocardial infarction.
1967
Long-term follow-up of patients with peripheral arterial obliterations treated with arterial surgery.
1975
HAEMODYNAMIC RESPONSES TO SUSTAINED HAND‐GRIP IN PATIENTS WITH HYPERTENSION
1970
Systemic Arterial Blood Pressure during Exercise in Patients with Atherosclerosis Obliterans of the Lower Limbs
1972
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
1982
Rankless by CCL
2026